224 related articles for article (PubMed ID: 12163100)
21. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
Hawkey CJ; Naesdal J; Wilson I; Långström G; Swannell AJ; Peacock RA; Yeomans ND
Gut; 2002 Sep; 51(3):336-43. PubMed ID: 12171953
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users.
Santolaria S; Lanas A; Benito R; Pérez-Aisa Mf; Montoro M; Sainz R
Aliment Pharmacol Ther; 1999 Nov; 13(11):1511-8. PubMed ID: 10571609
[TBL] [Abstract][Full Text] [Related]
23. Higher concentration of matrix-metalloproteinase 1 (interstitial collagenase) in H. pylori-compared to NSAID-induced gastric ulcers.
Menges M; Chan CC; Zeitz M; Stallmach A
Z Gastroenterol; 2000 Nov; 38(11):887-91. PubMed ID: 11132534
[TBL] [Abstract][Full Text] [Related]
24. The relation between Helicobacter pylori and nonsteroidal anti-inflammatory drugs.
Barkin J
Am J Med; 1998 Nov; 105(5A):22S-27S. PubMed ID: 9855172
[TBL] [Abstract][Full Text] [Related]
25. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients.
Chan HL; Wu JC; Chan FK; Choi CL; Ching JY; Lee YT; Leung WK; Lau JY; Chung SC; Sung JJ
Gastrointest Endosc; 2001 Apr; 53(4):438-42. PubMed ID: 11275883
[TBL] [Abstract][Full Text] [Related]
26. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.
Chan FK; To KF; Wu JC; Yung MY; Leung WK; Kwok T; Hui Y; Chan HL; Chan CS; Hui E; Woo J; Sung JJ
Lancet; 2002 Jan; 359(9300):9-13. PubMed ID: 11809180
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
Russell RI
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
[TBL] [Abstract][Full Text] [Related]
28. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.
Ootani H; Iwakiri R; Shimoda R; Nakahara S; Amemori S; Fujise T; Kikkawa A; Tsunada S; Sakata H; Fujimoto K
J Gastroenterol; 2006 Jan; 41(1):41-6. PubMed ID: 16501856
[TBL] [Abstract][Full Text] [Related]
29. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers.
Publig W; Wüstinger C; Zandl C
Wien Klin Wochenschr; 1994; 106(9):276-9. PubMed ID: 8023522
[TBL] [Abstract][Full Text] [Related]
30. [Role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users].
Shimada T; Yamagata M; Hiraishi H
Nihon Rinsho; 2007 Oct; 65(10):1824-9. PubMed ID: 17926531
[TBL] [Abstract][Full Text] [Related]
31. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F
Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
[TBL] [Abstract][Full Text] [Related]
32. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
al-Assi MT; Genta RM; Karttunen TJ; Graham DY
Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
[TBL] [Abstract][Full Text] [Related]
33. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
34. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
Chan FK
Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
[TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori, gastric ulcer, and agents noxious to the gastric mucosa.
Laine L
Gastroenterol Clin North Am; 1993 Mar; 22(1):117-25. PubMed ID: 8449561
[TBL] [Abstract][Full Text] [Related]
36. H. pylori eradication in NSAID-associated ulcers.
Drug Ther Bull; 2005 May; 43(5):37-40. PubMed ID: 15903114
[TBL] [Abstract][Full Text] [Related]
37. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
38. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
Tang CL; Ye F; Liu W; Pan XL; Qian J; Zhang GX
Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori and benign upper digestive disease.
Lai LH; Sung JJ
Best Pract Res Clin Gastroenterol; 2007; 21(2):261-79. PubMed ID: 17382276
[TBL] [Abstract][Full Text] [Related]
40. Non-Helicobacter pylori ulcer disease in rheumatoid arthritis patients receiving long-term NSAID therapy.
Mizokami Y; Narushima K; Shiraishi T; Otsubo T; Narasaka T; Matsuoka T
J Gastroenterol; 2000; 35 Suppl 12():38-41. PubMed ID: 10779216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
